| abstract |
COMBINATION OF TWO ANTIVIRALS FOR TREATMENT OF HEPATITIS C The present invention relates to interferon and ribavirin-free therapies for the treatment of HCV. Preferably, treatment takes place over a shorter duration of treatment, such as no longer than 12 weeks. In one aspect, the treatment comprises administering at least two direct-acting antiviral agents without interferon and ribavirin to a subject with HCV infection, wherein the treatment lasts for 12 weeks, and said two direct-acting antiviral agents comprise (a) Compound 1 or a pharmaceutically acceptable salt thereof and (b) Compound 2 or a pharmaceutically acceptable salt thereof. |